Back to Journals » Cancer Management and Research » Volume 11

Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy

Authors Jayaraj R, Kumarasamy C, Sabarimurugan S, Samiappan S

Received 25 December 2018

Accepted for publication 7 March 2019

Published 18 April 2019 Volume 2019:11 Pages 3349—3350

DOI https://doi.org/10.2147/CMAR.S199442

Checked for plagiarism Yes

Editor who approved publication: Dr Rituraj Purohit


Rama Jayaraj,1 Chellan Kumarasamy,2 Shanthi Sabarimurugan,3 Suja Samiappan4

1College of Health and Human Sciences, Charles Darwin University, Casuarina, Northern Territory 0909, Australia; 2University of Adelaide, Adelaide, South Australia 5005, Australia; 3School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India; 4Department of Biochemistry, Bharathiar University, Coimbatore, Tamil Nadu, India

Zhang and colleagues have conducted a network meta-analysis regarding fulvestrant combined targeted therapies for breast cancer, which has been published in the Cancer Management and Research journal.1 The study itself is interesting in its approach.

View the original paper by Zhang and colleagues.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]